Comparison of SEEOX and SOX Regimens in Stage ⅢB/ⅢC Gastric Cancer Patients

NCT02338518 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

297

Enrollment

OTHER

Sponsor class

Conditions

Stomach Neoplasms
Gastric Cancer

Interventions

DRUG: oxaliplatin
DRUG: etoposide
DRUG: pharmorubicin
DRUG: S-1

Sponsor

Jinling Hospital, China